Impact of Comprehensive and Intensive Treatment of Risk Factors Concerning Cardiovascular Mortality in Secondary Prevention: MIRVAS Study

详细信息    查看全文

• 作者：Miguel A. Moreno-Palanco^a ; ^{miguel.m.palanco@gmail.com} ; Patricia Ib&#xe1 ; ñ ; ez-Sanz^a ; Cristina Ciria-de Pablo^b ; Alberto Pizarro-Portillo^a ; Francisco Rodr&#xed ; guez-Salvan&#xe9 ; s^c ; Carmen Su&#xe1 ; rez-Fern&#xe1 ; ndez^a
• 关键词：Myocardial infarction ; Stroke ; Arterial hypertension ; Survival
• 刊名：Revista Española de Cardiología (English Edition)
• 出版年：2011
• 出版时间：March 2011
• 年：2011
• 卷：64
• 期：3
• 页码：179-185
• 全文大小：196 K

文摘

Introduction and objectives

The aim was to determine whether secondary prevention involving the comprehensive and intensive treatment of cardiovascular risk factors reduces cardiovascular events and cardiovascular mortality at 3-year follow up.

Methods

The study design comprised a randomized, controlled, open trial in a routine clinical practice setting. In total, 247 patients who presented with acute coronary syndrome or stroke were selected. They were randomized to comprehensive and intensive treatment of cardiovascular risk factors (n=121) or to follow-up based on usual care (n=126). The main study outcomes were the number of cardiovascular events and cardiovascular mortality at 3-year follow-up. The percentage of patients in whom each risk factor was successfully controlled was a secondary outcome.

Results

Overall, 88.8 % of patients assigned to the intensive treatment group had a low-density lipoprotein cholesterol level <100 mg/dl compared with 56.4 % of the usual-care group (relative risk [RR]=1.57; 95 % confidence interval [CI], 1.28-1.93), and 75.7 % of diabetics had a hemoglobin A_1c <7 % compared with 28.6 % of the usual-care group (RR=2.65; 95 % CI, 1.13-6.19). There were four deaths due to cardiovascular causes and 26 nonfatal events in the intensive treatment group versus 17 deaths and 54 nonfatal events in the usual-care group. The cumulative survival rate at 3 years was 97.4 % in the intervention group and 85.5 % in the control group (P=.003).

Conclusions

Secondary prevention involving comprehensive and intensive treatment of cardiovascular risk factors reduced both morbidity and mortality at 3-year follow up.